Search Login Register

gefitinib (Iressa) Summary

Description: structure in first source

Also Known As: Iressa; ZD1839; ZD 1839; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide

Networked: 2999 relevant articles (440 outcomes, 795 trials/studies) for this Drug

Key Diseases for which gefitinib is Relevant

  1. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) : 174 outcomes 298 studies in 1294 results
  2. Neoplasms (Cancer) : 96 outcomes 190 studies in 975 results
  3. Lung Neoplasms (Lung Cancer) : 64 outcomes 105 studies in 526 results
  4. Adenocarcinoma : 38 outcomes 59 studies in 247 results
  5. Neoplasm Metastasis (Metastasis) : 34 outcomes 19 studies in 164 results
Show All >>

Drugs Related to gefitinib

  1. Epidermal Growth Factor Receptor (EGF Receptor)
  2. Protein-Tyrosine Kinases (Tyrosine Kinase)
  3. erlotinib (CP 358,774)
  4. gefitinib (Iressa)
  5. Paclitaxel (Taxol)
  6. Platinum
  7. Carboplatin (JM8)
  8. docetaxel (Taxotere)
  9. Cisplatin (Platino)
  10. Phosphotransferases (Kinase)
Show All >>

Therapies Related to gefitinib

  1. Drug Therapy (Chemotherapy)
  2. Heterologous Transplantation (Xenotransplantation)
  3. Radiotherapy
  4. Combination Drug Therapy (Combination Chemotherapy)
  5. Retreatment
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.